Skip to content

A study evaluating three treatments for foot callus

A randomised controlled trial evaluating three treatments for plantar callus in healthy adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14751843
Enrollment
60
Registered
2015-04-30
Start date
2012-09-24
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Callus (or hard skin) Skin and Connective Tissue Diseases

Interventions

1. Removal of calluses using a surgical blade on day 1 of the study 2. Removal of calluses using potassium hydroxide based foot lotion once weekly for 3 weeks 3. Removal of calluses using a trichlorac

Sponsors

University of Salford (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participants were included if any of the following criteria applied: 1. They were aged 18 years and older 2. They had plantar callus 3. They had not been treated in the previous 6 weeks

Exclusion criteria

Exclusion criteria: Participants were excluded if any of the following criteria applied: 1. They had any skin disorders affecting the foot such as infections (e.g. Athlete’s foot), dermatitis, psoriasis, un-healed skin wounds, ulcers or blisters 2. They had a systematic disease including peripheral vascular disease or musculoskeletal disorders of the foot or ankle, rheumatoid arthritis or diabetes 3. They had allergies to any topical foot preparations with similar ingredients to those used in the trial treatments 4. They were unable to reach their feet to apply the products

Design outcomes

Primary

MeasureTime frame
The most painful or the largest callus was selected as the index callus. The primary outcome was complete clearance of the index callus at 3 weeks after randomisation as determined by assessment by a HCPC registered podiatrist. ‘Clearance’ of calluses was defined as the restoration of normal skin upon close inspection, with the return of normal dermatoglyphics to the treated skin.

Secondary

MeasureTime frame
1. Improvement in hydration, elasticity, skin surface texture and callus size at 7 days, 14 days and 21 days 2. Change in quality of life (QoL) before and 3 weeks after treatment 3. Satisfaction with treatment at 3 weeks

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 13, 2026